(function(){var loadHandler=window['sl_{811AD502-990C-42DF-95ED-9C2C63015009}'];loadHandler&&loadHandler(31, '<div id="spr0_995835d"><div id="spr1_995835d" class="kern slide"><img id="img4_995835d" src="data/img0.png" width="720px" height="405px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_995835d" class="kern slide"><div id="svg22_995835d" style="left:-0.693px;top:-5.182px;"><svg width="31" height="415" viewBox="0 0 31 415"><path fill="#c00000" fill-opacity="0.8" d="M0,0 h30.345 v414.682 h-30.345 Z"/></svg></div><div id="spr3_995835d" style="left:2.426px;top:418.302px;"><div style="width:0px;"><span id="txt0_995835d" class="relpos" data-width="284.130005" style="left:7.2px;top:4.513px;">Prothrombin complex concentrates</span> <span id="txt1_995835d" class="relpos" data-width="390.225586" style="left:7.195px;top:4.513px;"> generally include varied amounts of three to four</span></div><div style="width:0px;"><span id="txt2_995835d" data-width="647.279297" style="left:7.2px;top:26.113px;">factor concentrates, including factors II, IX, X, and sometimes VII. For most of the</span></div><div style="width:0px;"><span id="txt3_995835d" data-width="629.323242" style="left:7.2px;top:47.713px;">prothrombin complex concentrates, these factors are administered inactive and</span></div><div style="width:0px;"><span id="txt4_995835d" data-width="674.375977" style="left:7.2px;top:69.313px;">complexed with an anticoagulant such as antithrombin, protein C, or heparin, making</span></div><div style="width:0px;"><span id="txt5_995835d" data-width="642.313477" style="left:7.2px;top:90.913px;">the overall therapy less likely to cause unwanted thromboembolism. Prothrombin</span></div><div style="width:0px;"><span id="txt6_995835d" data-width="681.345703" style="left:7.2px;top:112.513px;">complex concentrates are currently indicated for treatment of hemophilia patients with</span></div><div style="width:0px;"><span id="txt7_995835d" data-width="699.345703" style="left:7.2px;top:134.113px;">inhibitors to specific factor concentrates. However, they are more frequently used as the</span></div><div style="width:0px;"><span id="txt8_995835d" data-width="692.332031" style="left:7.2px;top:155.713px;">first-line reversal agents for warfarin and the new oral anticoagulants in cases of critical</span></div><div style="width:0px;"><span id="txt9_995835d" data-width="682.338867" style="left:7.2px;top:177.313px;">bleeding. It is important to recognize that these medications carry a risk of arterial and</span></div><div style="width:0px;"><span id="txt10_995835d" data-width="681.389648" style="left:7.2px;top:198.913px;">venous thromboembolism and are contraindicated in patients with suspicion of having</span></div><div style="width:0px;"><span id="txt11_995835d" data-width="616.702148" style="left:7.2px;top:220.513px;">disseminated intravascular coagulation, or DIC.  DIC is a systemic disorder of</span></div><div style="width:0px;"><span id="txt12_995835d" data-width="699.363281" style="left:7.2px;top:242.113px;">uncontrolled hemostasis with microvascular clotting, decreased coagulation factors, and</span></div><div style="width:0px;"><span id="txt13_995835d" data-width="645.301758" style="left:7.2px;top:263.713px;">platelet consumption that may progress to multiorgan system failure and massive</span></div><div style="width:0px;"><span id="txt14_995835d" data-width="102.058594" style="left:7.2px;top:285.313px;">hemorrhage.</span></div></div><div id="spr4_995835d" style="left:29.652px;top:22.5px;"><div style="width:0px;"><span id="txt15_995835d" data-width="476.879883" style="left:107.111px;top:5.122px;">Prothrombin Complex Concentrates</span></div></div><div id="spr5_995835d" style="left:130px;top:114px;"><div style="width:0px;"><span id="txt16_995835d" data-width="86.053711" style="left:76.882px;top:19.995px;">Indications</span></div></div><div id="spr6_995835d" style="left:130px;top:114px;"><img id="img0_995835d" src="data/img143.png" width="243" height="61" alt=""/></div><div id="spr7_995835d" style="left:130px;top:114px;"><div style="width:0px;"><span id="txt17_995835d" data-width="86.053711" style="left:76.882px;top:18.42px;">Indications</span></div></div><div id="svg10_995835d" style="left:135.788px;top:168.491px;"><svg width="30" height="45" viewBox="-1 -2 30 45"><g fill="none"><g transform="translate(1,0)"><path stroke="#3d6696" stroke-width="2" stroke-linecap="butt" stroke-linejoin="round" d="M0,0 V40.638 H25.553"/></g></g></svg></div><div id="svg23_995835d" style="left:153.56px;top:174.257px;"><svg width="224" height="74" viewBox="-9.406 -9.406 224 74"><path fill="#ffffff" fill-opacity="0.9" stroke="#4a7ebc" stroke-width="0.8" stroke-linecap="butt" stroke-linejoin="round" d="M0.375,9.406 a9.031,9.031 0 0,1 9.031,-9.031 h186.361 a9.031,9.031 0 0,1 9.031,9.031 v36.123 a9.031,9.031 0 0,1 -9.031,9.031 h-186.361 a9.031,9.031 0 0,1 -9.031,-9.031 Z" fill-rule="evenodd"/></svg></div><div id="spr8_995835d" style="left:162.966px;top:183.663px;"><div style="width:0px;"><span id="txt18_995835d" data-width="194.097656" style="left:5.922px;top:16.488px;">Treatment of hemophilia</span></div></div><div id="svg21_995835d" style="left:135.788px;top:168.491px;"><svg width="30" height="113" viewBox="-1 -2 30 113"><g fill="none"><g transform="translate(1,0)"><path stroke="#3d6696" stroke-width="2" stroke-linecap="butt" stroke-linejoin="round" d="M0,0 V108.369 H25.553"/></g></g></svg></div><div id="svg24_995835d" style="left:153.56px;top:241.988px;"><svg width="224" height="74" viewBox="-9.406 -9.406 224 74"><path fill="#ffffff" fill-opacity="0.9" stroke="#4a7ebc" stroke-width="0.8" stroke-linecap="butt" stroke-linejoin="round" d="M0.375,9.406 a9.031,9.031 0 0,1 9.031,-9.031 h186.361 a9.031,9.031 0 0,1 9.031,9.031 v36.123 a9.031,9.031 0 0,1 -9.031,9.031 h-186.361 a9.031,9.031 0 0,1 -9.031,-9.031 Z" fill-rule="evenodd"/></svg></div><div id="spr9_995835d" style="left:162.966px;top:251.393px;"><div style="width:0px;"><span id="txt19_995835d" data-width="195.090820" style="left:5.087px;top:6.768px;">Reversal of warfarin and</span></div><div style="width:0px;"><span id="txt20_995835d" data-width="189.123047" style="left:8.087px;top:26.208px;">new oral anticoagulants</span></div></div><div id="spr10_995835d" style="left:255px;top:133px;"><div style="width:0px;"><span id="txt21_995835d" data-width="213.108398" style="left:12.309px;top:18.367px;">Risk of arterial and venous</span></div><div style="width:0px;"><span id="txt22_995835d" data-width="143.050781" style="left:47.309px;top:37.807px;">thromboembolism</span></div></div><div id="spr11_995835d" style="left:255px;top:133px;"><img id="img1_995835d" src="data/img144.png" width="240" height="78" alt=""/></div><div id="spr12_995835d" style="left:255px;top:133px;"><div style="width:0px;"><span id="txt23_995835d" data-width="213.108398" style="left:12.309px;top:16.793px;">Risk of arterial and venous</span></div><div style="width:0px;"><span id="txt24_995835d" data-width="143.050781" style="left:47.309px;top:36.233px;">thromboembolism</span></div></div><div id="spr13_995835d" style="left:255px;top:207px;"><div style="width:0px;"><span id="txt25_995835d" data-width="213.134766" style="left:12.309px;top:18.122px;">Contraindicated in patients</span></div><div style="width:0px;"><span id="txt26_995835d" data-width="68.009766" style="left:84.809px;top:37.562px;">with DIC</span></div></div><div id="spr14_995835d" style="left:255px;top:207px;"><img id="img2_995835d" src="data/img145.png" width="240" height="77" alt=""/></div><div id="spr15_995835d" style="left:255px;top:207px;"><div style="width:0px;"><span id="txt27_995835d" data-width="213.134766" style="left:12.309px;top:16.547px;">Contraindicated in patients</span></div><div style="width:0px;"><span id="txt28_995835d" data-width="68.009766" style="left:84.809px;top:35.987px;">with DIC</span></div></div><div id="spr16_995835d" style="left:414px;top:101px;"><img id="img3_995835d" src="data/img146.png" width="230" height="236" alt="undefined"/></div></div></div>');})();